Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin.
D007516:Adenoma, Islet Cell / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D003981:Diazoxide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006729:Hormones, Ectopic / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009922:Oregon; D010190:Pancreatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D012263:Ribonucleosides / Q000627:therapeutic use*; D013311:Streptozocin / Q000627:therapeutic use*; D014372:Tubercidin / Q000627:therapeutic use*
D006729:Hormones, Ectopic; D012263:Ribonucleosides; D013311:Streptozocin; D004317:Doxorubicin; D014372:Tubercidin; D003981:Diazoxide; D005472:Fluorouracil